U251-luc Orthotopic Model


U251-luc is a luminescent glioblastoma cell line derived from U251. It expresses luciferase, enabling non-invasive monitoring of tumor growth and response to treatments using bioluminescence imaging. U251-luc serves as a valuable tool for preclinical research in glioblastoma, allowing researchers to study tumor behavior, evaluate drug efficacy, and explore therapeutic approaches. This cell line offers a practical platform for investigating glioblastoma biology and developing novel treatment strategies.

Model Details

Cancer Type: Brain Cancer
Model Name: U251-luc
Mouse Strain: Nu/Nu
Treatment Data Available: Chemotherapy (Temolozide)

U251-luc Survival

Survival of U251-luc after orthotopic intracranial injection in Nu/Nu mice (n=5)

Request Additional Syngeneic Model Data

Contact Us

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our
expert staff today to get started.

Skip to content